Receipt
Filed June 15, 2026
The short version
Scott Galloway predicted on January 5, 2024: “If 2023 was the year of GPT-4, 2024 will be the year of GLP-1. That is, Ozempic, Mounjaro, and all GLP-1-related weight loss and diabetes treatment drugs.” Verdict: Called it. GLP-1 drugs did become a major economic and media narrative, with substantial market-cap gains for pharma and widespread discussion of their impact across…
Prediction by
Scott Galloway
On January 5, 2024
“If 2023 was the year of GPT-4, 2024 will be the year of GLP-1. That is, Ozempic, Mounjaro, and all GLP-1-related weight loss and diabetes treatment drugs.”
Follow-up
GLP-1 drugs did become a major economic and media narrative, with substantial market-cap gains for pharma and widespread discussion of their impact across various sectors, aligning with Galloway's prediction of it being the defining 'tech of the year' economically.
Original source
No Mercy / No MaliceFrom the High Caliber AI network — see the AI for PR module in the course.